Literature DB >> 33546361

Intestinal Stem Cell Development in the Neonatal Gut: Pathways Regulating Development and Relevance to Necrotizing Enterocolitis.

Aparna Venkatraman1, Wei Yu1, Christopher Nitkin1, Venkatesh Sampath1.   

Abstract

The intestine is extremely dynamic and the epithelial cells that line the intestine get replaced every 3-5 days by highly proliferative intestinal stem cells (ISCs). The instructions for ISCs to self-renew or to differentiate come as cues from their surrounding microenvironment or their niche. A small number of evolutionarily conserved signaling pathways act as a critical regulator of the stem cells in the adult intestine, and these pathways are well characterized. However, the mechanisms, nutritional, and environmental signals that help establish the stem cell niche in the neonatal intestine are less studied. Deciphering the key signaling pathways that regulate the development and maintenance of the stem cells is particularly important to understanding how the intestine regenerates from necrotizing enterocolitis, a devastating disease in newborn infants characterized by inflammation, tissues necrosis, and stem cell injury. In this review, we piece together current knowledge on morphogenetic and immune pathways that regulate intestinal stem cell in neonates and highlight how the cross talk among these pathways affect tissue regeneration. We further discuss how these key pathways are perturbed in NEC and review the scientific knowledge relating to options for stem cell therapy in NEC gleaned from pre-clinical experimental models of NEC.

Entities:  

Keywords:  exosomes; immune signaling; intestinal stem cells; mesenchymal stem cell therapy; morphogentic pathways; necrotizing enterocolits

Year:  2021        PMID: 33546361      PMCID: PMC7913590          DOI: 10.3390/cells10020312

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  142 in total

1.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

2.  Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.

Authors:  Eduard Batlle; Jeffrey T Henderson; Harry Beghtel; Maaike M W van den Born; Elena Sancho; Gerwin Huls; Jan Meeldijk; Jennifer Robertson; Marc van de Wetering; Tony Pawson; Hans Clevers
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

3.  SIGIRR genetic variants in premature infants with necrotizing enterocolitis.

Authors:  Venkatesh Sampath; Heather Menden; Daniel Helbling; Keguo Li; Adam Gastonguay; Ramani Ramchandran; David P Dimmock
Journal:  Pediatrics       Date:  2015-05-11       Impact factor: 7.124

4.  Treatment of experimental necrotizing enterocolitis with stem cell-derived exosomes.

Authors:  Christopher J McCulloh; Jacob K Olson; Yijie Wang; Yu Zhou; Natalie Huibregtse Tengberg; Shivani Deshpande; Gail E Besner
Journal:  J Pediatr Surg       Date:  2018-03-14       Impact factor: 2.545

5.  Perspective: The Role of Human Breast-Milk Extracellular Vesicles in Child Health and Disease.

Authors:  Daniel O'Reilly; Denis Dorodnykh; Nina V Avdeenko; Nikita A Nekliudov; Johan Garssen; Ahmed A Elolimy; Loukia Petrou; Melanie Rae Simpson; Laxmi Yeruva; Daniel Munblit
Journal:  Adv Nutr       Date:  2021-02-01       Impact factor: 8.701

6.  Bmp signaling is required for intestinal growth and morphogenesis.

Authors:  Lorene E Batts; D Brent Polk; Raymond N Dubois; Holger Kulessa
Journal:  Dev Dyn       Date:  2006-06       Impact factor: 3.780

Review 7.  TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization.

Authors:  Cecilia Garlanda; Hans-Joachim Anders; Alberto Mantovani
Journal:  Trends Immunol       Date:  2009-08-21       Impact factor: 16.687

8.  Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls.

Authors:  Christopher J Stewart; Nicholas D Embleton; Emma C L Marrs; Daniel P Smith; Tatiana Fofanova; Andrew Nelson; Tom Skeath; John D Perry; Joseph F Petrosino; Janet E Berrington; Stephen P Cummings
Journal:  Microbiome       Date:  2017-07-12       Impact factor: 14.650

9.  Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases.

Authors:  Yu Wang; Wei Long; Yan Cao; Jingyun Li; Lianghui You; Yuru Fan
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

10.  Adipose-derived mesenchymal stem cells attenuate acute lung injury and improve the gut microbiota in septic rats.

Authors:  Junyi Sun; Xianfei Ding; Shaohua Liu; Xiaoguang Duan; Huoyan Liang; Tongwen Sun
Journal:  Stem Cell Res Ther       Date:  2020-09-07       Impact factor: 6.832

View more
  2 in total

1.  Age disparities in intestinal stem cell quantities: a possible explanation for preterm infant susceptibility to necrotizing enterocolitis.

Authors:  Brian D Hosfield; W Christopher Shelley; Fikir M Mesfin; John P Brokaw; Krishna Manohar; Jianyun Liu; Hongge Li; Anthony R Pecoraro; Kanhaiya Singh; Troy A Markel
Journal:  Pediatr Surg Int       Date:  2022-10-08       Impact factor: 2.003

Review 2.  Stem cell therapy as a promising strategy in necrotizing enterocolitis.

Authors:  Si-Jia Di; Si-Yuan Wu; Tian-Jing Liu; Yong-Yan Shi
Journal:  Mol Med       Date:  2022-09-06       Impact factor: 6.376

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.